Michael Sinha, professor in the Center for Health Law Studies at Saint Louis University School of Law, joins Megan Lynch with a look at the recent Supreme Court decision to temporarily stay a lower court ruling on mail-order mifepristone. Louisiana originally brought the lawsuit against the FDA to challenge Biden administration rules that expanded access to mifepristone by removing the requirement that patients see a provider in person before getting the medication. Sinha says there has been a, 'longstanding history focusing on these type of products,' related to abortion. (Photo illustration by Natalie Behring/Getty Images)
May 05, 2026
